Meetings dates for SQPs to find out about parasite control
Frimley, 20.09.11 – Novartis Animal Health is inviting vets and SQPs to take part in a series of CPD (Continued Professional Development) meetings that will provide an update on the major parasites of importance in cattle.
The meetings will take place at locations around the country in October and feature two talks. The first will be ‘Cattle Ectoparasites: What’s New and Important?’ and the second talk will be ‘Update on Fluke and Recommendations for Parasite Control at Housing’. The events will allow SQPs to gain CPD points.
Dr Peter Bates, (Veterinary Medical Entomology Consultancy), or Dr Sian Mitchell MRCVS, (Veterinary Laboratories Agency) will be speaking first with the second talks being given by one of the Novartis Animal Health Professional Services Veterinarians.
The meetings will take place at Smiths Hotel, Gretna Green at 7pm on 4th October; at The Mytton and Mermaid, Atcham, Shrewsbury, and The Forge Hotel, St Clears, Carmarthenshire, at 7pm on 5th October; at The Venue at Park Hall, Oswestry, Shropshire at 12pm and at the Padbrook Park Hotel, Cullompton, Devon at 7pm on 6th October.
Helen Langham, Novartis Brand Manager says : “This is an ideal opportunity for prescribers of animal health products to receive up to date information from key speakers about the important ectoparasites of cattle including all types of mange and lice. Alongside this, we recognise liver fluke continues to be of increasing importance so will give the latest advice and recommendations about how to effectively treat for this serious disease. Bringing the sessions together, we will end with the provision of a suggested protocol for cattle parasite control for the winter”.
“The events will also be an opportunity to meet and speak with fellow colleagues in an informal environment, and there will be plenty of opportunity to ask questions of our speakers. SQPs will have the chance to earn CPD points and vets CPD hours from these meetings and food will be provided,” she said.
For further information and to book a place please telephone 01276 694402 referencing the Cattle Winter Parasite Meeting series.
Disclaimer
The foregoing release contains forward-looking statements that can be identified by terminology such as “will,” or similar expressions, or by express or implied discussions regarding potential new indications or labeling for Novartis Animal Health products or regarding potential future revenues from . You should not place undue reliance on these statements. Such forward-looking statements reflect the current views of management regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results with Novartis Animal Health products to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that Novartis Animal Health products will be approved for any additional indications or labeling in any market. Nor can there be any guarantee that Novartis Animal Health products will achieve any particular levels of revenue in the future. In particular, management’s expectations regarding Novartis Animal Health products could be affected by, among other things, unexpected regulatory actions or delays or government regulation generally; unexpected clinical trial results, including unexpected new clinical data and unexpected additional analysis of existing clinical data; the company’s ability to obtain or maintain patent or other proprietary intellectual property protection; competition in general; government, industry and general public pricing pressures; the impact that the foregoing factors could have on the values attributed to the Novartis Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and factors referred to in Novartis AG’s current Form 20-F on file with the US Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.
About Novartis Animal Health
Novartis Animal Health researches, develops and commercializes leading animal treatments that meet the needs of pet owners, farmers and veterinarians. Headquartered in Basel, Switzerland and present in nearly 40 countries, Novartis Animal Health employs approximately 2,700 people worldwide. For more information, please visit www.ah.novartis.com
About Novartis
Novartis provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care, cost-saving generic pharmaceuticals, consumer health products, preventive vaccines and diagnostic tools. Novartis is the only company with leading positions in these areas. In 2010, the Group’s continuing operations achieved net sales of USD 50.6 billion, while approximately USD 9.1 billion (USD 8.1 billion excluding impairment and amortization charges) was invested in R&D throughout the Group. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 121,000 full-time-equivalent associates and operate in more than 140 countries around the world. For more information, please visit http://www.novartis.com.
Novartis is on Twitter. Sign up to follow @Novartis at http://twitter.com/novartis.
# # #
For further information
| Helen LanghamNovartis Animal Health UK Ltd+44 1276 694402helen.langham@novartis.com | Henry CreaghKendalls Communications+44 1394 610022henry.creagh@kendallscom.co.uk |
For Novartis multimedia content, please visit www.thenewsmarket.com/Novartis
For questions about the site or required registration, please contact: journalisthelp@thenewsmarket.com.
About Novartis Animal Health
Novartis Animal Health is a leader in developing new and better ways to prevent and treat diseases in pets, farm animals and cultivated fish. We focus our energy on developing new medicines that improve the quality of life for companion animals, as well as those that improve the health of livestock and farmed fish as we strive to support high-quality production and welfare.
For further information, please contact:
Novartis UK Press Office 44 (0) 1276 698691
Helen Langham, Novartis Animal Health, 01276 694402, helen.langham@novartis.com
Henry Creagh, Kendalls Communications, 01394 610022, henry.creagh@kendallscom.co.uk
Tags: